Income Taxes	9 Months Ended
Mar. 30, 2013
Income Tax Disclosure [Abstract]
Income Taxes [Text Block]	INCOME TAXES In the three and nine months ended March 30, 2013, the Company recorded an income tax provision of $22.8 million and $92.7 million, respectively, compared to an income tax provision of $88.9 million and $152.5 million in the three and nine months ended March 31, 2012, respectively. In addition, the Company recorded income tax that was netted against income from discontinued operations of $0.7 million for the three and nine months ended March 30, 2013 and $13.6 million for the three and nine months ended March 31, 2012. The Company's federal statutory tax rate is 35%. The Company's income tax provision for the three and nine months ended March 30, 2013 was lower than the amount computed by applying the statutory tax rate primarily because the earnings of foreign subsidiaries were taxed at lower rates. The Company's income tax provision for the three and nine months ended March 30, 2013 included a $7.1 million benefit for research tax credits for the fiscal year 2012 and first two quarters of fiscal year 2013 that were generated by the retroactive extension of the federal research tax credit to January 1, 2012 by legislation that was signed into law on January 2, 2013. The Company's income tax provision for the nine months ended March 30, 2013 included a $21.4 million discrete tax charge for research and development expenses of a foreign subsidiary for which no tax benefit was available. The Company's income tax provision for the three and nine months ended March 31, 2012 was higher than the amount computed by applying the statutory tax rate primarily because of a $56.0 million discrete tax charge for research and development expenses of a foreign subsidiary for which no tax benefit was available. In fiscal year 2012 the U.S. Internal Revenue Service commenced an audit of the Company's federal corporate income tax returns for fiscal years 2009 through 2011, which is still ongoing.

Income Taxes

9 Months Ended

Mar. 30, 2013

INCOME TAXES

In the three and nine months ended March 30, 2013, the Company recorded an income tax provision of $22.8 million and $92.7 million, respectively, compared to an income tax provision of $88.9 million and $152.5 million in the three and nine months ended March 31, 2012, respectively. In addition, the Company recorded income tax that was netted against income from discontinued operations of $0.7 million for the three and nine months ended March 30, 2013 and $13.6 million for the three and nine months ended March 31, 2012.

The Company's federal statutory tax rate is 35%. The Company's income tax provision for the three and nine months ended March 30, 2013 was lower than the amount computed by applying the statutory tax rate primarily because the earnings of foreign subsidiaries were taxed at lower rates. The Company's income tax provision for the three and nine months ended March 30, 2013 included a $7.1 million benefit for research tax credits for the fiscal year 2012 and first two quarters of fiscal year 2013 that were generated by the retroactive extension of the federal research tax credit to January 1, 2012 by legislation that was signed into law on January 2, 2013. The Company's income tax provision for the nine months ended March 30, 2013 included a $21.4 million discrete tax charge for research and development expenses of a foreign subsidiary for which no tax benefit was available.

The Company's income tax provision for the three and nine months ended March 31, 2012 was higher than the amount computed by applying the statutory tax rate primarily because of a $56.0 million discrete tax charge for research and development expenses of a foreign subsidiary for which no tax benefit was available.

In fiscal year 2012 the U.S. Internal Revenue Service commenced an audit of the Company's federal corporate income tax returns for fiscal years 2009 through 2011, which is still ongoing.